Kaio Maciel de Santiago-Silva

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

Trypanosoma Cruzi

Respiratory Syndrome Coronavirus

Top Venues

Scientific reports

Journal of biomolecular structure & dynamics

Antibiotics (Basel, Switzerland)

Current drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Giovanna Barbosa Frensel, Diego Allonso, Gerson Nakazato, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Scientific reports 14 (1) (2024)
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Giovanna Barbosa Frensel, Diego Allonso, Gerson Nakazato, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Scientific reports 14 (1) (2024)
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Giovanna Barbosa Frensel, Diego Allonso, Gerson Nakazato, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Scientific reports 14 (1) (2024)
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Larissa Esteves Carvalho Constant, Stephany da Silva Costa, Giovanna Barbosa Frensel, Diego Allonso, Gerson Nakazato, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo
Molecular modelling studies and in vitro enzymatic assays identified A 4-(nitrobenzyl)guanidine derivative as inhibitor of SARS-CoV-2 Mpro. Scientific reports 14 (1) (2024)
Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, Marcieli Fabris, Priscila Goes Camargo, Marcelle de Lima Ferreira Bispo
Proteasome as a Drug Target in Trypanosomatid Diseases. Current drug targets (2023)
Kaio Maciel de Santiago-Silva, Priscila Goes Camargo, Gabriel Felix da Silva Gomes, Ana Paula Sotero, Alexandre Orsato, Carla Cristina Perez, Gerson Nakazato, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo
In silico approach identified benzoylguanidines as SARS-CoV-2 main protease (M pro ) potential inhibitors. Journal of biomolecular structure & dynamics (2022)
Gabriel Felix da Silva Gomes, Priscila Goes Camargo, Kaio Maciel de Santiago-Silva, Helena Tiemi Suzukawa, Ana Paula Sotero, Alexandre Orsato, Gerson Nakazato, Sueli Fumie Yamada-Ogatta, Ligia Carla Faccin Galhardi, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo, Carla Cristina Perez
In silico approaches and in vitro assays identify a coumarin derivative as antiviral potential against SARS-CoV-2. Journal of biomolecular structure & dynamics (2022)
Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Laudicéa do Nascimento Oliveira, Fernanda Lima de Azevedo Maia, Joyce Cristina Castro, Ivete Conchon Costa, Danielle Bidóia Lazarin, James L Wardell, Solange M S V Wardell, Magaly Girão Albuquerque, Camilo Henrique da Silva Lima, Wander Rogério Pavanelli, Marcelle de Lima Ferreira Bispo, Raoni Schroeder B Gonçalves
Antileishmanial Activity of 4,8-Dimethoxynaphthalenyl Chalcones on Leishmania amazonensis . Antibiotics (Basel, Switzerland) 11 (10) (2022)
Kaio Maciel de Santiago-Silva, Bruna Taciane da Silva Bortoleti, Tiago de Oliveira Brito, Ivete Conchon Costa, Camilo Henrique da Silva Lima, Fernando Macedo, Milena Menegazzo Miranda-Sapla, Wander Rogério Pavanelli, Marcelle de Lima Ferreira Bispo
Exploring the antileishmanial activity of N1,N2-disubstituted-benzoylguanidines: synthesis and molecular modeling studies. Journal of biomolecular structure & dynamics (2021)